Literature DB >> 3261609

An epidemiological study of scleroderma in the West Midlands.

A Silman1, S Jannini, D Symmons, P Bacon.   

Abstract

A population based study of the occurrence of scleroderma was carried out on the 4.1 million adult residents of the West Midlands Region. Seven separate sources were used to obtain cases. This first epidemiological study of scleroderma in the UK suggests prevalence rates of 13 and 48 per million in males and females respectively, with annual incidence rates of 1 and 6 per million. The peak age of onset is between 45 and 54 but new cases continue to arise even during the eighth decade. There is a pronounced female excess, with a ratio of 6:1, this excess being particularly marked in those under 45. It is difficult to assess the completeness of notification and thus the estimates should be considered as minimum. There are, however, suggestions in these data that the completeness of recording was high.

Entities:  

Mesh:

Year:  1988        PMID: 3261609     DOI: 10.1093/rheumatology/27.4.286

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  27 in total

1.  The natural course of progressive systemic sclerosis patients with interstitial lung involvement.

Authors:  Musellim Benan; Ikitimur Hande; Ongen Gul
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

2.  What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?

Authors:  A J Silman; S Jones
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 3.  Scleroderma and survival.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

Review 4.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

5.  Renal disease in systemic sclerosis with normal serum creatinine.

Authors:  Reem H A Mohamed; Hania S Zayed; Amr Amin
Journal:  Clin Rheumatol       Date:  2010-02-23       Impact factor: 2.980

Review 6.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 7.  Systemic sclerosis: a world wide global analysis.

Authors:  Paola Coral-Alvarado; Aryce L Pardo; Natalia Castaño-Rodriguez; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Clin Rheumatol       Date:  2009-03-11       Impact factor: 2.980

8.  Therapies for scleroderma-related pulmonary arterial hypertension.

Authors:  Paul M Hassoun
Journal:  Expert Rev Respir Med       Date:  2009       Impact factor: 3.772

9.  Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA.

Authors:  A O Adebajo; A J Crisp; A Nicholls; B L Hazleman
Journal:  Postgrad Med J       Date:  1992-03       Impact factor: 2.401

Review 10.  Pulmonary arterial hypertension in connective tissue diseases.

Authors:  Stephen C Mathai; Paul M Hassoun
Journal:  Heart Fail Clin       Date:  2012-07       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.